C-aryl glucoside SGLT2 inhibitors and method | Patent Publication Number 20020137903

US 20020137903 A1
Patent NumberUS 06515117 B2
Application Number10151436
Filled DateMay 20, 2002
Priority DateOct 12, 1999
Publication DateSep 26, 2002
Original AssigneeBristol Myers Squibb
Current AssigneeAstrazeneca
Inventor/ApplicantsBruce Ellsworth
Philip M. Sher
William N. Washburn
Philip M. Sher
Wei Meng
Bruce Ellsworth
Gang Wu
Gang Wu
William N. Washburn
Wei Meng
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.